Life, Interrupted: Brotherly Love

Life, Interrupted

Suleika Jaouad writes about her experiences as a young adult with cancer.

There are a lot of things about having cancer in your 20s that feel absurd. One of those instances was when I found myself calling my brother Adam on Skype while he was studying abroad in Argentina to tell him that I had just been diagnosed with leukemia and that — no pressure — he was my only hope for a cure.

Today, my brother and I share almost identical DNA, the result of a successful bone marrow transplant I had last April using his healthy stem cells. But Adam and I couldn’t be more different. Like a lot of siblings, we got along swimmingly at one moment and were in each other’s hair the next. My younger brother by two years, he said I was a bossy older sister. I, of course, thought I knew best for my little brother and wanted him to see the world how I did. My brother is quieter, more reflective. I’m a chronic social butterfly who is probably a bit too impulsive and self-serious. I dreamed of dancing in the New York City Ballet, and he imagined himself playing in the N.B.A. While the sounds of the rapper Mos Def blared from Adam’s room growing up, I practiced for concerto competitions. Friends joked that one of us had to be adopted. We even look different, some people say. But really, we’re just siblings like any others.

When I was diagnosed with cancer at age 22, I learned just how much cancer affects families when it affects individuals. My doctors informed me that I had a high-risk form of leukemia and that a bone marrow transplant was my only shot at a cure. ‘Did I have any siblings?’ the doctors asked immediately. That would be my best chance to find a bone marrow match. Suddenly, everyone in our family was leaning on the little brother. He was in his last semester of college, and while his friends were applying to jobs and partying the final weeks of the school year away, he was soon shuttling from upstate New York to New York City for appointments with the transplant doctors.

I’d heard of organ transplants before, but what was a bone marrow transplant? The extent of my knowledge about bone marrow came from French cuisine: the fancy dish occasionally served with a side of toasted baguette.

Jokes aside, I learned that cancer patients become quick studies in the human body and how cancer treatment works. The thought of going through a bone marrow transplant, which in my case called for a life-threatening dose of chemotherapy followed by a total replacement of my body’s bone marrow, was scary enough. But then I learned that finding a donor can be the scariest part of all.

It turns out that not all transplants are created equal. Without a match, the path to a cure becomes much less certain, in many cases even impossible. This is particularly true for minorities and people from mixed ethnic backgrounds, groups that are severely underrepresented in bone marrow registries. As a first generation American, the child of a Swiss mother and Tunisian father, I suddenly found myself in a scary place. My doctors worried that a global, harried search for a bone marrow match would delay critical treatment for my fast-moving leukemia.

That meant that my younger brother was my best hope — but my doctors were careful to measure hope with reality. Siblings are the best chance for a match, but a match only happens about 25 percent of the time.

To our relief, results showed that my brother was a perfect match: a 10-out-of-10 on the donor scale. It was only then that it struck me how lucky I had been. Doctors never said it this way, but without a match, my chances of living through the next year were low. I have met many people since who, after dozens of efforts to encourage potential bone marrow donors to sign up, still have not found a match. Adding your name to the bone marrow registry is quick, easy and painless — you can sign up at marrow.org — and it just takes a swab of a Q-tip to get your DNA. For cancer patients around the world, it could mean a cure.

The bone marrow transplant procedure itself can be dangerous, but it is swift, which makes it feel strangely anti-climactic. On “Day Zero,” my brother’s stem cells dripped into my veins from a hanging I.V. bag, and it was all over in minutes. Doctors tell me that the hardest part of the transplant is recovering from it. I’ve found that to be true, and I’ve also recognized that the same is true for Adam. As I slowly grow stronger, my little brother has assumed a caretaker role in my life. I carry his blood cells — the ones keeping me alive — and he is carrying the responsibility, and often fear and anxiety, of the loving onlooker. He tells me I’m still a bossy older sister. But our relationship is now changed forever. I have to look to him for support and guidance more than I ever have. He’ll always be my little brother, but he’s growing up fast.


Suleika Jaouad (pronounced su-LAKE-uh ja-WAD) is a 24-year-old writer who lives in New York City. Her column, “Life, Interrupted,” chronicling her experiences as a young adult with cancer, appears regularly on Well. Follow @suleikajaouad on Twitter.

Read More..

Intel 4th-Quarter Earnings Are Sharply Lower


SAN FRANCISCO — Intel has money, smart people and resolve, but it still doesn’t have a quick fix for the deterioration of its largest market — personal computers.


The world’s biggest maker of semiconductors, which grew by supplying chips to most of the world’s personal computer makers, is now facing an erosion of that market. According to Gartner, a market analysis firm, PC shipments worldwide declined 3.5 percent in 2012.


The result was evident Thursday in Intel’s fourth-quarter earnings report. The company, which is based in Santa Clara, Calif., reported net income of $2.5 billion, or 48 cents a share, down 27 percent from $3.4 billion, or 64 cents a share, a year earlier. Revenue fell 3 percent to $13.5 billion from $13.9 billion.


“The PC business as we’ve known it is evolving,” said Paul S. Otellini, Intel’s chief executive, in a call to Wall Street analysts. “The form factors are going to blur here.”


Instead of PCs, more people and businesses are buying smartphones and tablets. Intel gets 64 percent of its revenues and some of its highest profit margins from chips for PCs. It has scrambled to revive the market, while it aggressively tries to supply tablet and smartphone makers, so far with little success.


But even as its gets harder to sell PCs, Intel appears to have managed its business better than many investors thought possible. Revenue was in line with analysts’ expectations, according to a survey by Thomson Reuters, but net income was higher than the 45 cents a share that the analysts were expecting, on average.


Intel projected lower revenue and pressure on its profit margins for 2013, however, which sent its shares down about 5 percent in after-hours trading. Shares of Intel finished regular trading Thursday at $22.68, up 57 cents.


At the after-hours price, Intel’s market capitalization dropped below that of Qualcomm, a smaller maker of chips, but a company that makes chips for smartphones and tablets. Even a year ago, this would have been unthinkable.


Over the last six months, shares of Intel have fallen about 18 percent, while Qualcomm’s stock is up almost 20 percent. ARM Holdings, which sells designs for low-power chips popular in mobile devices, is up almost 90 percent in that time.


“Longer term, Intel will move more aggressively into smartphones,” said Bobby Burleson, an analyst with Canaccord Genuity. “But everyone worries about their long-term gross margins.”


Intel, which employs an engineering-focused staff of 105,000 people, plans to continue to invest heavily in research and development, as well as new manufacturing facilities. Intel operates on the principle that making the biggest volumes of the most advanced chips gives it a quality and profit margin advantage.


Despite the lower earnings, Intel said it would spend $18.9 billion on research and development, along with marketing and administrative costs, in 2013. Two years ago Intel spent $16 billion on those things, increasing that amount to $18.2 billion last year.


“Our manufacturing leadership becomes increasingly valuable,” said Stacy J. Smith, Intel’s chief financial officer. “People expect Intel to make more powerful, more efficient devices. That applies across all our businesses.”


That works, as long as the chips have buyers. Last year Intel hoped two PC industry initiatives would woo buyers back to PCs, but neither did. One, backed by a large investment from Intel, was in lightweight ultrabook laptop computers, many of which had tablet features, like touch screens. These came to market later than analysts had expected, at prices most consumers did not find attractive.


The other, Microsoft’s release of its Windows 8 operating system, has so far failed to excite buyers. Consumers and businesses did not buy new computers in order to use the upgraded system.


Mr. Otellini remained upbeat about ultrabooks, saying that there were now 140 types of the lightweight laptops on the market. The number of styles and different ways they use things like keyboards and touch screens, he said, would make it harder to tell a PC from a tablet.


“We’re in the midst of a radical transformation with the blurring of form factors,” he said, adding that next year Intel would introduce a new chip, called Haswell, which would help in the production of lightweight machines that have longer battery life. He said little about Windows 8.


Intel’s second-largest business, chips for computer servers in data centers, reflected an overall strength in that industry. Fourth-quarter sales to data centers was $2.8 billion, an increase of 4 percent from a year earlier.


Read More..

JPMorgan, Goldman profits rise sharply









NEW YORK — Two major Wall Street banks reported a surge in profits during the last three months of 2012, but analysts cast doubt on whether that will continue this year.


JPMorgan Chase & Co., the country's largest bank by assets, posted $5.7 billion in earnings in the fourth quarter, a 53% increase from the same period a year ago. Investment banking giant Goldman Sachs Group Inc. reported earnings of $2.8 billion, nearly tripling its haul from the same period a year ago.


The results sailed past analyst projections, providing a window into Wall Street's profitability as the economy struggles to recover and as the industry grapples with new banking regulations.





"We're definitely coming out of the abyss," said Ken Leon, a banking analyst at S&P Capital IQ. But, he cautioned: "We are not anywhere near euphoria."


Investors sent both firms' shares higher Wednesday, during a week in which Citigroup, Bank of America and Morgan Stanley will also report earnings.


JPMorgan's profit was buoyed by growth tied to an improving housing market, investment banking and its own investments. The bank reported big jumps in mortgages — originations of $52 million, up 33%. Commercial loans grew 14% in the fourth quarter, to a record $128 billion.


The bank's profit also got a boost from reserves released because of borrowers' improving credit and the decreased likelihood they would default on their loans.


JPMorgan's earnings were weighed down by an approximately $700-million expense for its chunk of the so-called Independent Foreclosure Review settlement. The bank was one of 10 major financial companies that reached the $8.5-billion settlement — announced last week — with federal regulators to end their probe of alleged foreclosure abuses.


While the bank saw a 12% jump in profit overall last year thanks in large part to a decline in provisions for credit losses, revenue was essentially flat compared to 2011.


Despite JPMorgan's surge in profit, the bank's board punished Chairman and Chief Executive Jamie Dimon for management failures that led to the bank suffering about $6 billion in losses from risky derivatives bets made by a trader nicknamed the "London Whale."


JPMorgan's board of directors slashed Dimon's pay 50%, saying he "bears ultimate responsibility" for missteps by the bank's chief investment office. The losses were disclosed last May.


"This was one huge, embarrassing mistake," he said.


One of the highest-paid and most-respected figures on Wall Street, Dimon will take in $11.5 million in 2012 compensation, down from a $23-million pay package in 2011.


His 2012 salary remained flat at last year's $1.5 million, but his overall compensation includes $10 million in restricted stock units, down sharply from the previous year. Dimon said he respected the board's decision.


Charles Elson, director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, said the rare docking of a major bank chief's pay made an important symbolic statement that executives should be paid based on their performance.


"It's not going to change his lifestyle," Elson said of Dimon's pay cut, "but it certainly makes the point."


Looking ahead, Dimon expressed optimism about the economy.


"Consumers, businesses, housing and small businesses — they're all in pretty good shape," he said in a call with analysts.


But sustaining growth in mortgage origination could prove challenging this year, and low interest rates make traditional banking less profitable, analysts said.


"Traditional banking is not making nearly as much money," said Lance Roberts, who heads StreetTalk Advisors, an investment advisory firm. "There's a big disconnect between the profitability of the banks and Main Street America."


While Goldman's profit in investment banking and trading surged, the bank's results were lifted by its own private-equity investments and an 11% reduction in compensation, Goldman's biggest expense. Goldman has become a profit powerhouse and its employees are among the most highly compensated on Wall Street.


JPMorgan's stock added 47 cents, or 1%, to $46.82 in trading Wednesday. Goldman gained $5.50, or 4%, to $141.09 a share.


andrew.tangel@latimes.com





Read More..

Judge Tells Apple, Amazon to Try to Settle Their 'Appstore' Beef











The judge presiding over the Apple and Amazon lawsuit over rights to the “appstore” name has told the two companies to sit down and at least try to settle their dispute before trial.


San Francisco U.S. Magistrate Judge Elizabeth Laporte issued an order Tuesday telling the two sides to talk it out. This doesn’t mean they’ll come to terms before the August 19 trial, but they must at least pretend to try.


If the talks, first reported by Bloomberg, don’t lead to a settlement, the mess lands in U.S. District Judge Phyllis Hamilton’s courtroom in Oakland. Hamilton, like Laporte, seems tired of the bickering. On January 2, Hamilton dismissed Apple’s claim that the Amazon Appstore for Android was falsely advertising itself as an app store for iOS apps. No one is confusing the Appstore for Apple’s App Store, she said.


Apple filed its lawsuit against Amazon the day the Appstore for Android (which only sells apps that run on Google’s Android operating system) went live, back on March 22, 2011. The iPhone maker is accusing Amazon of infringing on its copyrighted “App Store” name. Meanwhile, Amazon countersued Apple, arguing that “app store” is a generic phrase and that Apple shouldn’t be the only company to use the term.






Read More..

Fox hires Dennis Kucinich as analyst






NEW YORK (AP) — Days before President Barack Obama‘s inauguration for a second term in office, Fox News Channel has signed Dennis Kucinich, one of his former opponents, to be a regular contributor.


Kucinich, a presidential candidate in 2004 and 2008 who ended 16 years in Congress two weeks ago, will make his debut as a Fox contributor on Thursday’s edition of “The O’Reilly Factor,” the network said Wednesday.






“I’ve always been impressed with Rep. Kucinich’s fearlessness and thoughtfulness about important issues,” Fox News Chairman Roger Ailes said. “His willingness to take a stand from his point of view makes him a valuable voice in our country’s debate.”


Fox is the nation’s top-ranked cable news network, particularly popular with Republicans. Its big-name Republican contributors include Karl Rove, Sarah Palin and John Bolton. Democrats in the Fox stable include Evan Bayh, Joe Trippi and Bob Beckel.


Kucinich was elected to the Cleveland city council at age 23 and, at 31, became one of the nation’s youngest mayors. He’s also been an Ohio state senator and run his own communications and marketing firm.


“Fox News has always provided me with an opportunity to share my perspective with its enormous viewership,” he said.


Entertainment News Headlines – Yahoo! News





Title Post: Fox hires Dennis Kucinich as analyst
Url Post: http://www.news.fluser.com/fox-hires-dennis-kucinich-as-analyst/
Link To Post : Fox hires Dennis Kucinich as analyst
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Study Confirms Benefits of Flu Vaccine for Pregnant Women


While everyone is being urged to get the flu vaccine as soon as possible, some pregnant women avoid it in the belief that it may harm their babies. A large new study confirms that they should be much more afraid of the flu than the vaccine.


Norwegian researchers studied fetal death among 113,331 women pregnant during the H1N1 flu pandemic of 2009-2010. Some 54,065 women were unvaccinated, 31,912 were vaccinated during pregnancy, and 27,354 were vaccinated after delivery. The scientists then reviewed hospitalizations and doctor visits for the flu among the women.


The results were published on Thursday in The New England Journal of Medicine.


The flu vaccine was not associated with an increased risk for fetal death, the researchers found, and getting the shot during pregnancy reduced the risk of the mother getting the flu by about 70 percent. That was important, because fetuses whose mothers got the flu were much more likely to die.


Unvaccinated women had a 25 percent higher risk of fetal death during the pandemic than those who had had the shot. Among pregnant women with a clinical diagnosis of influenza, the risk of fetal death was nearly doubled. In all, there were 16 fetal deaths among the 2,278 women who were diagnosed with influenza during pregnancy.


Dr. Marian Knight, a professor at the perinatal epidemiology unit of the University of Oxford, who was not involved in the research, called it “a high-quality national study” that shows “there is no evidence of an increased risk of fetal death in women who have been immunized. Clinicians and women can be reassured about the safety of the vaccine in the second and third trimesters of pregnancy.”


The Norwegian health system records vaccinations of individuals and maintains linked registries to track effects and side effects. The lead author, Dr. Camilla Stoltenberg, director of the Norwegian Institute of Public Health, said that there are few countries with such complete records.


“This is a great study,” said Dr. Denise J. Jamieson, an obstetrician and a medical officer at the Centers for Disease Control and Prevention, who was not involved in the work. “It’s nicely done, with good data, and it’s additional information about the importance of the flu vaccine for pregnant women. It shows that it’s effective and might reduce the risk for fetal death.”


In Norway, the vaccine is recommended only in the second and third trimesters, so the study includes little data on vaccination in the first trimester. The C.D.C. recommends the vaccine for all pregnant women, regardless of trimester.


“We knew from other studies that the vaccine protects the woman and the newborn,” Dr. Stoltenberg said. “This study clearly indicates that it protects fetuses as well. I seriously suggest that pregnant women get vaccinated during every flu season.”


Read More..

F.A.A. Orders Grounding of U.S.-Operated Boeing 787s


Kyodo News, via Reuters


An All Nippon Airways Boeing 787 Dreamliner made an emergency landing at Takamatsu airport in western Japan on Wednesday.







The Federal Aviation Administration said Wednesday that it was temporarily grounding all Boeing 787s operated by United States carriers after several incidents in recent weeks, including a battery fire, and after an All Nippon Airways flight in Japan was forced to make an emergency landing on Wednesday.




The F.A.A.'s emergency airworthiness directive only applies directly to United Airlines, currently the sole American carrier using the new plane, with six 787s. But the agency said it would alert other aviation regulators to take similar action, and it seems likely that international carriers will comply with the directive.


Eight airlines now fly the plane, known as the Dreamliner. All Nippon Airways and Japan Airlines in Japan own 24 of the 49 delivered by Boeing since November 2011. The other operators are Air India, Ethiopian Airlines, LAN Airlines of Chile, LOT of Poland and Qatar Airways. Orders for about 800 additional 787s are in the pipeline.


“The F.A.A. will work with the manufacturer and carriers to develop a corrective action plan to allow the U.S. 787 fleet to resume operations as quickly and safely as possible,” the F.A.A. said in a statement.


Thanks to its extensive use of lighter composite materials and more efficient engines, the 787 is expected to usher a new era of more fuel-efficient travel, particularly over long distances.


But so far, the aircraft’s problems have been linked to a feature that had garnered much less attention until now: the 787’s extensive use of electric systems. Unlike modern passenger jets built in the past decades, which use mechanical and pneumatic systems to power hydraulic pumps, the 787 makes extensive use of electrical systems instead.


The emergency landing of the All Nippon plane on Wednesday followed a string of problems in the past month with the 787, including a battery fire, fuel leaks and a cracked cockpit window. All Nippon said the problems Wednesday involved the same lithium-ion batteries that caught fire last week in Boston on a Dreamliner operated by Japan Airlines.


In the episode early Wednesday, the 137 passengers and crew members aboard a flight from Yamaguchi Ube Airport, in western Japan, to Tokyo used emergency slides to leave the aircraft early after battery trouble and an “unusual smell” in the cockpit prompted its pilots to land instead at Takamatsu airport, according to All Nippon. The jet’s main battery in the front of the plane was later found to have become discolored and to be seeping electrolyte fluid, All Nippon said.


Ryosei Nomura, a spokesman for All Nippon, said Wednesday that the airline was temporarily grounding all 17 of its Dreamliners for inspections, leading to the cancellation of 38 domestic and international flights. Japan Airlines also said it would ground the five Dreamliners it was operating; two other aircraft were already undergoing safety checks.


Last week, the F.A.A. ordered a comprehensive review of the Dreamliner’s manufacturing and design, with a focus on the plane’s electrical systems. During a news conference last Thursday, Transportation Secretary Ray LaHood made no mention of grounding Dreamliners.


Hiroko Tabuchi contributed reporting from Tokyo, and Bettina Wassener from Hong Kong.



This article has been revised to reflect the following correction:

Correction: January 16, 2013

An earlier version of this article published online misstated the number of Boeing 787s already delivered worldwide. It is 49, not 50.



Read More..

San Diego Zoo, Audubon pair up to help save animals









SAN DIEGO — Two organizations known for their work in saving imperiled species agreed Tuesday to build a breeding center that will bring some of the world's most exotic and endangered birds and hoofed mammals to a 1,000-acre site near the Mississippi River.


The new facility will include open-air enclosures for animals of more than two dozen species, including whooping cranes, okapis, bongos (a type of antelope), storks, flamingos, Masai giraffes, oryx and other creatures, under the agreement signed by the San Diego Zoo Global and New Orleans-based Audubon Nature Institute.


"They have the land and we have the majority of the species that need assistance," said Robert Wiese, chief life sciences officer for San Diego Zoo Global, which manages field programs in 35 countries.





The partnership is based on the realization that animals breed better when they have room to roam. Even at the San Diego Zoo's ample Safari Park, space has become pinched.


The new facility, south of New Orleans, is to be named the Alliance for Sustainable Wildlife.


Many of the species are imperiled by loss of habitat in their native Africa, officials said.


For example, the okapi, an unusual animal that looks a zebra but is related to the giraffe, is threatened by the volatile politics of Central Africa and the continued loss of dense rain forest habitat. The brightly colored bongo, among the largest of the African antelope species, is threatened by poaching and habitat loss in Central and West Africa.


"We want to retain a large population in case the worst happens in Africa," Wiese said.


Jim Maddy, president and chief executive of the Assn. of Zoos and Aquariums, said the partnership "demonstrates the creativity and resourcefulness of these two great organizations."


The Audubon Nature Institute, which operates museums and parks in the New Orleans area, owns the property, which already includes a research facility and a breeding center for cranes.


Construction at the center is set to begin this fall; the breeding program is expected to get underway next year. The San Diego Zoo will transfer some of its animals to the site. There are no plans in the first years to permit public access.


Douglas Myers, president of San Diego Zoo Global, said the two organizations hope the alliance "will be a model for collaborative efforts in the future."


The 1,000-acre site has sufficient elevation and drainage to withstand flooding from storms that sweep in from the Gulf of Mexico, officials said. The site, once owned by the Coast Guard, suffered only slight damage from Hurricane Katrina in 2005.


Still, "there is no totally safe, risk-free place," Wiese said.


tony.perry@latimes.com





Read More..

Syria Dropped Hallucinogen Weapon on Rebels, Secret Cable Says



The Syrian military used an exotic chemical weapon on rebels during an attack in the city of Homs, U.S. officials now believe.


The conclusion — first reported by Foreign Policy’s Josh Rogin and laid out in a secret cable from the U.S. consul general in Istanbul — contradicts preliminary estimates made by American officials in the hours after the December 23 strike. But after interviews with Syrian activists, doctors, and defectors, the U.S. has apparently rendered a different verdict.


“We can’t definitely say 100 percent, but Syrian contacts made a compelling case that Agent 15 was used in Homs on Dec. 23,” an unnamed U.S. official tells Rogin. Danger Room has been unable to independently verify the claims. It’s important to note that this was the conclusion of a single consulate within the State Department, and there is still wide disagreement within the U.S. government over whether the Homs attack should be characterized as a chemical weapons incident.


Agent 15 is another name for 3-quinuclidinyl benzilate or BZ, a powerful hallucinogen that the American military tested out on its own soldiers during the Cold War. Its emergence on the Syrian battlefield would be nothing short of bizarre. While Syria is well-known to have a massive supply of chemical weapons, international observers haven’t ordinarily included BZ on that list. And while there have been rumors of BZ being used on a battlefield — including one that Iraqi insurgents were dosing themselves with the drug to pump up their aggressiveness — this would be the first confirmed case of BZ employed as a weapon.


International leaders, including President Obama, have called the use of chemical arms in Syria a “red line” that could trigger outside intervention in the civil war that has killed more than 60,000 people. It’s unclear whether the White House would consider a BZ strike to be a transgression of that line; Agent 15 isn’t nearly as deadly as a nerve agent like sarin. Last week, America’s top military officer said preventing a chemical attack by the Assad regime would be “almost unachievable.”


American and allied intelligence services have been watching the Syrian government’s acquisition and possible use of chemical weapon components for years. They’ve blocked the importation of precursor chemicals and equipment into Syria when they’ve been able, and immediately reported to the White House when the Syrian military began mixing those precursor chemicals and loading them into munitions for a possible attack.


But when U.S. officials first caught wind of Syrian rebels’ chemical weapons claim, the officials didn’t make much of it. In graphic videos uploaded to YouTube, opposition activists said they were hit by a gas that was “something similar to sarin,” a deadly nerve agent. The videos showed victims howling in agony and barely able to breathe. But the symptoms, as gruesome as they were, didn’t seem like the one produced by sarin.


There were complaints of strong smells in the videos; sarin is odorless. There were reports that the victims inhaled large amounts of the chemical; a minuscule of amount of inhaled sarin can be fatal.


“It just doesn’t jibe with chemical weapons,” one U.S. official told Danger Room at the time.


But the loss of vision, pain, dizziness, and paralysis reported by the Syrian American Medical Society may correspond more closely with a different kind of unconventional attack.


Read More..

Singer Jessica Simpson to star in TV comedy






LOS ANGELES (Reuters) – Pop singer Jessica Simpson is set to star in a television pilot in development for NBC that is loosely based on her life, executive producer Ben Silverman said on Tuesday.


The comedy could be Simpson‘s first step back into a major acting role in more than five years.






The former teen pop star is best known for her reality TV shows, including MTV’s “Newlyweds: Nick and Jessica,” which followed Simpson and her first husband and fellow pop singer Nick Lachey. She also served as a mentor on NBC’s “Fashion Star.”


Simpson, 32, will play a celebrity who must balance life as a mother and a public figure, Silverman told Reuters.


The singer gave birth to her first child in May 2012 and said last month that she was pregnant with her second.


“The show is inspired by her life as she’s going through a new phase in her life becoming a mom,” said Silverman, who is the creator of NBC’s reality show “The Biggest Loser.”


“It’s a combination of ‘I Love Lucy’ and ‘Curb Your Enthusiasm,’” he added, referring to the classic 1950s Lucille Ball comedy series and the HBO series by “Seinfeld” creator Larry David.


Simpson will also serve as an executive producer.


In 2004, Simpson taped a pilot for the ABC network about a pop star who becomes a TV news anchor, but it never became a series.


Simpson’s film credits include 2005′s “The Dukes of Hazzard” and 2006′s “Employee of the Month.”


(Reporting by Eric Kelsey, editing by Jill Serjeant and Stacey Joyce)


TV News Headlines – Yahoo! News





Title Post: Singer Jessica Simpson to star in TV comedy
Url Post: http://www.news.fluser.com/singer-jessica-simpson-to-star-in-tv-comedy/
Link To Post : Singer Jessica Simpson to star in TV comedy
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..